Relapsed B-cell Acute Lymphoblastic Leukemia
7 clinical trials · Condition
◉ Watch Relapsed B-cell Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Blinatumomab Bridging Therapy for BALL (NCT04556084) | Michael Burke | 2021-01-01 |
| A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects (NCT03156101) | Shenzhen BinDeBio Ltd. | 2017-03-02 |
| Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia (NCT02808442) | Institut de Recherches Internationales Servier | 2016-06-03 |
| Study of Efficacy and Safety of CTL019 in Adult ALL Patients (NCT02167360) | Abramson Cancer Center at Penn Medicine | 2016-06-01 |
| Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients (NCT02228096) | Novartis Pharmaceuticals | 2014-08-14 |
| T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia (NCT01860937) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
Track Relapsed B-cell Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.